Viewing Study NCT04501718


Ignite Creation Date: 2025-12-25 @ 4:50 AM
Ignite Modification Date: 2025-12-26 @ 3:51 AM
Study NCT ID: NCT04501718
Status: RECRUITING
Last Update Posted: 2024-10-15
First Post: 2020-08-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Apatinib Combined with Temozolomide and Etoposide Capsules in the Treatment of Recurrent Medulloblastoma in Children
Sponsor: Beijing Sanbo Brain Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module